Name: FDA approves ketamine-derived nasal spray
Uploaded: Wed Mar 06 2019 13:12:07 GMT+0000 (UTC)
Duration: 26 s
Description: The FDA has approved esketamine nasal spray that could help certain patients with severe, treatment-resistant depression. The spray contains a variation of the pain reliever ketamine, which was widely abused in the ‘80s and ‘90s.

March 6, 201900:26